JUSTIN DAILEY: Open Payments
NPI 1184332116 · BEL AIR, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,239 in 95 payments from 25 companies in 2025. Trend: 2023 $1,596 · 2024 $1,785 · 2025 $2,239
Food & beverage: $2,239
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 20 | $315 |
| ABBVIE INC. | 13 | $282 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $227 |
| Teleflex LLC | 2 | $138 |
| Antares Pharma, Inc. | 6 | $136 |
| PFIZER INC. | 8 | $131 |
| Novartis Pharmaceuticals Corporation | 5 | $123 |
| Valencia Technologies Corporation | 1 | $98 |
| Janssen Biotech, Inc. | 4 | $95 |
| Dendreon Pharmaceuticals LLC | 4 | $94 |
Products named: BOTOX, Nubeqa, GEMTESA, XTANDI, BARRIGEL, PLUVICTO, XYOSTED, eCoin Device Kit.
Industry payments across MD — which companies pay providers there.
